ANXA4 and cardiovascular disorder: Finally, recognizing differences in coverage across the proteome and transcriptome, we found three targets common to both PWAS and TWAS with supportive evidence in cardiovascular disease, specifically MIF (inflammation68), HEXIM1 (cardiac development69), and ANXA4 (electrophysiologic properties70).